| Literature DB >> 18162140 |
Gloria Luz Paniagua1, Eric Monroy, Octavio García-González, Javier Alonso, Erasmo Negrete, Sergio Vaca.
Abstract
BACKGROUND: Diarrhoeal diseases constitute a major public health problem, particularly in the developing world, where the rate of mortality and morbidity is very high. The purpose of this study was to conduct a 2 years and 3 months study in order to determine the prevalence of five enteropathogen diarrheogenic agents in Mexico City.Entities:
Mesh:
Year: 2007 PMID: 18162140 PMCID: PMC2246149 DOI: 10.1186/1476-0711-6-17
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
Prevalence of enteropathogens among the studied populations.
| 211 (70.3) | 35 (43.7) | |
| 99 (33.0) | 16 (20.0) | |
| 85 (28.3) | 2 (2.5) | |
| 49 (16.3) | 1 (1.2) | |
| ETEC | 40 (13.3) | 2 (2.5) |
| EPEC | 28 (9.3) | 1 (1.2) |
| 24 (8.0) | 0 | |
| VTEC | 26 (8.6) | 1(1.2) |
| 5 (1.6) | 0 | |
| 3 (1.0) | 0 | |
| EIEC | 3 (1.0) | 0 |
| 2 (0.6) | 0 | |
| 1 (0.3) | 0 |
ETEC, enterotoxigenic E. coli; EPEC, enteropathogenic E. coli; VTEC, verotoxigenic E. coli; EIEC, enteroinvasive E. coli.
Association patterns of enteropathogens in patient group stool samples.
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| Subjects with different associations | 22 |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 3 | |
| 7 | |
| 7 | |
| 7 | |
| Subjects with different associations | 10 |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 3 | |
| 3 | |
| 3 | |
| 6 | |
| 14 | |
| 23 | |
| Subjects with different associations | 10 |
*n: number of subjects positive for indicated enteropathogens; abbreviations are the same as indicated in Table 1.
Diarrhoegenic E. coli identified in stool samples.
| ETEC | ||
| | 10 (3.3) | 1 (1.2) |
| | 20 (6.6) | 1 (1.2) |
| | 10 (3.3) | 0 |
| EPEC | ||
| | 23 (7.6) | 1 (1.2) |
| | 5 (1.7) | 0 |
| VTEC | ||
| | 17 (5.6) | 1 (1.2) |
| | 5 (1.6) | 0 |
| | 4 (1.3) | 0 |
| EIEC | ||
| | 3 (1.0) | 0 |
| Total | 97 (32) | 4(5) |
χ2 represents statistical difference between both groups studied (P < 0.001). Abbreviations are the same as indicated in Table 1.
Figure 12.5% Agarose gel electrophoresis of E. coli amplicons obtained from diarrhoeal samples (run conditions 120 V, 94 mA, 45 min.). Lane 1: VTEC ATCC43889 and ATCC43890 strains (positive control). Lane 2: Negative control without template DNA. Lane 3: EPEC ATCC43887 strain (positive control). Lane 4: ETEC ATCC 35401 (positive control); Lane 5: EIEC ATCC43893 (positive control). Lane 6: E. coli ATCC11775 (avirulent strain, negative control). Lane 7: MWM 50-bp ladder. Lane 8: EPEC (patient group sample). Lane 9: negative sample (control group). Lane 10; negative sample (control group). Lane 11; VTEC (patient group sample). Lane 12; negative sample (patient group). Lane 13; EIEC (patient group sample). Lane 14; ETEC (patient group sample).
Figure 2(A) 2.5% Agarose gel electrophoresis of Salmonella phase I flagellar amplicons obtained from diarrhoeal samples. Lane 1: Negative control without template DNA. Lanes 2, 3, 4 10 and 12; S. ohio (150 bp) (patient group). Lanes 5, 6 and 11; negative samples (patient group). Lane 7 S. typhimurium (patient group). Lane 8; MWM 50 bp ladder. Lane 9; S. infantis (patient group); Lane 11; Negative sample (patient group); Lane 13; Salmonella anatum (patient group). (B) 2.5% agarose gel electrophoresis of Salmonella phase II flagellar amplicons obtained from diarrhoeal samples. Lanes 1, 8 and 10, negative samples (patient group); Lane 2, Negative control without template DNA; Lane 3, Salmonella anatum (patient group); Lane 4, S. typhimurium (patient group); Lane 5, MWM 50 bp ladder; Lane 6, S. infantis (patient group); Lanes 7 and 9, S. ohio (patient group). For both electrophoresis, run conditions were 120 V, 94 mA, 45 min.